In one paragraphArticle in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
8 authors.
Heather GreenleeHeather Greenlee, PhD, and Eileen Rillamas-Sun, PhD, MPH, Fred Hutchinson Cancer Center, Seattle, WA; Richard Cheng, MD, MSc, University of Washington, Seattle, WA; and Carlos Iribarren, MD, MPH, PhD, Jamal S. Rana, MD, PhD, Mai Nguyen-Huynh, MD, MAS, Lawrence H. Kushi, ScD, and Marilyn L. Kwan, PhD, Kaiser Permanente Northern California, Oakland, CA.ORCID 0000-0003-4148-1405 Eileen Rillamas-SunHeather Greenlee, PhD, and Eileen Rillamas-Sun, PhD, MPH, Fred Hutchinson Cancer Center, Seattle, WA; Richard Cheng, MD, MSc, University of Washington, Seattle, WA; and Carlos Iribarren, MD, MPH, PhD, Jamal S. Rana, MD, PhD, Mai Nguyen-Huynh, MD, MAS, Lawrence H. Kushi, ScD, and Marilyn L. Kwan, PhD, Kaiser Permanente Northern California, Oakland, CA.ORCID 0000-0002-8637-0437 Richard ChengHeather Greenlee, PhD, and Eileen Rillamas-Sun, PhD, MPH, Fred Hutchinson Cancer Center, Seattle, WA; Richard Cheng, MD, MSc, University of Washington, Seattle, WA; and Carlos Iribarren, MD, MPH, PhD, Jamal S. Rana, MD, PhD, Mai Nguyen-Huynh, MD, MAS, Lawrence H. Kushi, ScD, and Marilyn L. Kwan, PhD, Kaiser Permanente Northern California, Oakland, CA.ORCID 0000-0001-5994-5998 Carlos IribarrenHeather Greenlee, PhD, and Eileen Rillamas-Sun, PhD, MPH, Fred Hutchinson Cancer Center, Seattle, WA; Richard Cheng, MD, MSc, University of Washington, Seattle, WA; and Carlos Iribarren, MD, MPH, PhD, Jamal S. Rana, MD, PhD, Mai Nguyen-Huynh, MD, MAS, Lawrence H. Kushi, ScD, and Marilyn L. Kwan, PhD, Kaiser Permanente Northern California, Oakland, CA.ORCID 0000-0001-5622-1839 Jamal S RanaHeather Greenlee, PhD, and Eileen Rillamas-Sun, PhD, MPH, Fred Hutchinson Cancer Center, Seattle, WA; Richard Cheng, MD, MSc, University of Washington, Seattle, WA; and Carlos Iribarren, MD, MPH, PhD, Jamal S. Rana, MD, PhD, Mai Nguyen-Huynh, MD, MAS, Lawrence H. Kushi, ScD, and Marilyn L. Kwan, PhD, Kaiser Permanente Northern California, Oakland, CA.
Mai Nguyen-HuynhHeather Greenlee, PhD, and Eileen Rillamas-Sun, PhD, MPH, Fred Hutchinson Cancer Center, Seattle, WA; Richard Cheng, MD, MSc, University of Washington, Seattle, WA; and Carlos Iribarren, MD, MPH, PhD, Jamal S. Rana, MD, PhD, Mai Nguyen-Huynh, MD, MAS, Lawrence H. Kushi, ScD, and Marilyn L. Kwan, PhD, Kaiser Permanente Northern California, Oakland, CA.ORCID 0000-0002-8228-0282 Lawrence H KushiHeather Greenlee, PhD, and Eileen Rillamas-Sun, PhD, MPH, Fred Hutchinson Cancer Center, Seattle, WA; Richard Cheng, MD, MSc, University of Washington, Seattle, WA; and Carlos Iribarren, MD, MPH, PhD, Jamal S. Rana, MD, PhD, Mai Nguyen-Huynh, MD, MAS, Lawrence H. Kushi, ScD, and Marilyn L. Kwan, PhD, Kaiser Permanente Northern California, Oakland, CA.ORCID 0000-0001-9136-1175 Funding
Infrastructure for Pathways, a Prospective Study of Breast Cancer SurvivorshipU01CA195565 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI AMBROSONE, CHRISTINE B., KUSHI, LAWRENCE H · 2016 to 2025
$18.8MPredictors of CVD among breast cancer survivors in an integrated health systemR01CA214057 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI GREENLEE, HEATHER, KWAN, MARILYN L · 2017 to 2020
$2.6MNCI NIH HHS R01 CA214057NCI NIH HHS U01 CA195565
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID35878101
PMCPMC9746758
What OpenQuestion holds
Textmetadata
Read underepoch 390